1. A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3. (16th November 2015) Authors: Erickson, Stephen W.; Stephens, Owen W.; Chavan, Shweta S.; Epstein, Joshua; Barlogie, Bart; Heuck, Christoph J.; Vangsted, Annette J. Journal: British journal of haematology Issue: Volume 174:Number 6(2016) Page Start: 991 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Allelic mutations in noncoding genomic sequences construct novel transcription factor binding sites that promote gene overexpression. Issue 11 (29th July 2015) Authors: Tian, Erming; Børset, Magne; Sawyer, Jeffrey R.; Brede, Gaute; Våtsveen, Thea K.; Hov, Håkon; Waage, Anders; Barlogie, Bart; Shaughnessy, John D.; Epstein, Joshua; Sundan, Anders Journal: Genes, chromosomes & cancer Issue: Volume 54:Issue 11(2015:Nov.) Page Start: 692 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biomarkers that Discriminate Multiple Myeloma Patients with or without Skeletal Involvement Detected Using SELDI-TOF Mass Spectrometry and Statistical and Machine Learning Tools. Issue 4 (9th June 2013) Authors: Bhattacharyya, Sudeepa; Epstein, Joshua; Suva, Larry J. Journal: Disease markers Issue: Volume 22:Issue 4(2006) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial. Issue 10068 (4th February 2017) Authors: Durie, Brian G M; Hoering, Antje; Abidi, Muneer H; Rajkumar, S Vincent; Epstein, Joshua; Kahanic, Stephen P; Thakuri, Mohan; Reu, Frederic; Reynolds, Christopher M; Sexton, Rachael; Orlowski, Robert Z; Barlogie, Bart; Dispenzieri, Angela Journal: Lancet Issue: Volume 389:Issue 10068(2017) Page Start: 519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease. Issue 8 (1st June 2017) Authors: Mohan, Meera; Buros, Amy; Mathur, Pankaj; Gokden, Neriman; Singh, Manisha; Susanibar, Sandra; Jo Kamimoto, Jorge; Hoque, Shadiqul; Radhakrishnan, Muthukumar; Matin, Aasiya; Davis, Cynthia; Grazziutti, Monica; Thanendrarajan, Sharmilan; van Rhee, Frits; Zangari, Maurizio; Davies, Faith; Morgan, Ga... Journal: American journal of hematology Issue: Volume 92:Issue 8(2017:Aug.) Page Start: 739 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients. Issue 1 (January 2015) Authors: Szmania, Susann; Lapteva, Natalia; Garg, Tarun; Greenway, Amy; Lingo, Joshuah; Nair, Bijay; Stone, Katie; Woods, Emily; Khan, Junaid; Stivers, Justin; Panozzo, Susan; Campana, Dario; Bellamy, William T.; Robbins, Molly; Epstein, Joshua; Yaccoby, Shmuel; Waheed, Sarah; Gee, Adrian; Cottler-Fox, Mi... Journal: Journal of immunotherapy Issue: Volume 38:Issue 1(2015:Jan.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes. Issue 7 (17th March 2014) Authors: Tian, Erming; Sawyer, Jeffrey R.; Heuck, Christoph J.; Zhang, Qing; van, Frits; Barlogie, Bart; Epstein, Joshua Journal: Genes, chromosomes & cancer Issue: Volume 53:Issue 7(2014:Jul.) Page Start: 549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Mesenchymal stem cells gene signature in high‐risk myeloma bone marrow linked to suppression of distinct IGFBP2‐expressing small adipocytes. (8th November 2018) Authors: Mehdi, Syed J.; Johnson, Sarah K.; Epstein, Joshua; Zangari, Maurizio; Qu, Pingping; Hoering, Antje; van Rhee, Frits; Schinke, Carolina; Thanendrarajan, Sharmilan; Barlogie, Bart; Davies, Faith E.; Morgan, Gareth J.; Yaccoby, Shmuel Journal: British journal of haematology Issue: Volume 184:Number 4(2019) Page Start: 578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?. (March 2016) Authors: Thanendrarajan, Sharmilan; Davies, Faith E; Morgan, Gareth J; Schinke, Carolina; Mathur, Pankaj; Heuck, Christoph J; Zangari, Maurizio; Epstein, Joshua; Yaccoby, Shmuel; Weinhold, Niels; Barlogie, Bart; van Rhee, Frits Journal: Immunotherapy Issue: Volume 8:Number 3(2016:Mar.) Page Start: 367 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Removing batch effects from purified plasma cell gene expression microarrays with modified ComBat. Issue 1 (December 2015) Authors: Stein, Caleb; Qu, Pingping; Epstein, Joshua; Buros, Amy; Rosenthal, Adam; Crowley, John; Morgan, Gareth; Barlogie, Bart Journal: BMC bioinformatics Issue: Volume 16:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗